Cargando…

Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis

IMPORTANCE: Neurologic adverse events (NAEs) due to immune checkpoint inhibitors (ICIs) can be fatal but are underexplored. OBJECTIVE: To compare NAEs reported in randomized clinical trials (RCTs) of US Food and Drug Administration–approved ICIs with other forms of chemotherapy and placebo. DATA SOU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farooq, Muhammad Zain, Aqeel, Sheeba Ba, Lingamaneni, Prasanth, Pichardo, Rayli Carolina, Jawed, Aleeza, Khalid, Saad, Banskota, Shristi Upadhyay, Fu, Pingfu, Mangla, Ankit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020216/ https://www.ncbi.nlm.nih.gov/pubmed/35438755 http://dx.doi.org/10.1001/jamanetworkopen.2022.7722

Ejemplares similares

Identifying predictors and evaluating the role of steroids in the prevention of post-embolization syndrome after transarterial chemoembolization and bland embolization
por: Agrawal, Rohit, et al.
Publicado: (2021)

Neurological Adverse Effects of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T-Cell Therapy
por: Khalid, Farhan, et al.
Publicado: (2023)

HIV-associated Non-small-cell Lung Cancer with Rearrangement of the Anaplastic Lymphoma Kinase Gene: A Report of Two Patients
por: Pichardo, Rayli, et al.
Publicado: (2019)

Defining the Role of the Gut Microbiome in the Pathogenesis and Treatment of Lymphoid Malignancies
por: Upadhyay Banskota, Shristi, et al.
Publicado: (2023)

Angiotensinogen as a biomarker of acute kidney injury
por: Ba Aqeel, Sheeba Habeeb, et al.
Publicado: (2017)

Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy
por: Möhn, Nora, et al.
Publicado: (2020)

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors
por: Guidon, Amanda C, et al.
Publicado: (2021)

Simulation of a large number of interacting charged particles trapped in a Penning trap on the BioDynaMo platform
por: Rayli, Melike
Publicado: (2023)

Superior Mesenteric Artery Syndrome: A Vicious Cycle?
por: Jawed, Aleeza, et al.
Publicado: (2023)

A rare case of perforated jejunal diverticula of an uncommon origin
por: Jawed, Aleeza, et al.
Publicado: (2023)

Correction: Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors
Publicado: (2021)

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events
por: Müller-Jensen, Leonie, et al.
Publicado: (2023)

Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
por: Zhou, Yanting, et al.
Publicado: (2023)

FRI539 Vitamin D and Endocrine Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
por: He, Zijun, et al.
Publicado: (2023)

Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
por: Abu Omar, Yazan, et al.
Publicado: (2019)

Heparin-Induced Thrombocytopenia in COVID-19
por: Lingamaneni, Prasanth, et al.
Publicado: (2020)

Polycythemia in a Patient With Atonic Bladder and Hydronephrosis
por: Katiyar, Vatsala, et al.
Publicado: (2021)

Tilapia Consumption and Scombroid Poisoning
por: Edigin, Ehizogie, et al.
Publicado: (2019)

350. Neurocysticercosis – Gender Differences in Clinical Presentations
por: Pendyala, Bharath, et al.
Publicado: (2020)

351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
por: Pendyala, Bharath, et al.
Publicado: (2020)

Merkel Cell Carcinoma With Isolated Pancreatic Metastasis
por: Lingamaneni, Prasanth, et al.
Publicado: (2021)

Tumor Lysis Syndrome in a Patient With Gastric Adenocarcinoma
por: Lingamaneni, Prasanth, et al.
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
por: Mangla, Ankit
Publicado: (2023)

Immune-mediated Colitis from Dual Checkpoint Inhibitors
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Recurrent solitary fibrous tumor of lumbar spine with vertebral body involvement: imaging features and differential diagnosis with report of a case
por: Farooq, Zerwa, et al.
Publicado: (2016)

Neuroprotective Strategies for Neurological Disorders by Natural  Products: An update
por: Rehman, Muneeb U., et al.
Publicado: (2019)

Loperamide Induced Life Threatening Ventricular Arrhythmia
por: Upadhyay, Ankit, et al.
Publicado: (2016)

Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development
por: Cheng, Ke, et al.
Publicado: (2021)

Rotary Endodontics in Pediatric Dentistry: Embracing the New Alternative
por: Chauhan, Ananya, et al.
Publicado: (2019)

Pentachlorophenol has significant adverse effects on hematopoietic and immune system development in zebrafish (Danio rerio)
por: Namit, Aleeza, et al.
Publicado: (2022)

Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
por: Farina, Antonio, et al.
Publicado: (2023)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Neurologic adverse events of cancer immunotherapy
por: de Brito, Marcelo Houat
Publicado: (2022)

Immune checkpoint inhibitors as potential triggers for ANCA vasculitis
por: Aqeel, Faten, et al.
Publicado: (2022)

Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019)

Management of the Adverse Effects of Immune Checkpoint Inhibitors
por: Morgado, Manuel, et al.
Publicado: (2020)

Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Their Cardiovascular Adverse Effects
por: Paluri, Ravi Kumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f3q9u3aurvhbf6cr81djtijbcv